Personalized Cancer Care with RGCC
About Us
RGCC (Research Genetic Cancer Centre) was founded in 2004 by genetics pioneer Dr. Ioannis Papasotiriou, driven by his belief that personalized medicine, tailored to a patient’s unique genetic profile, is the key to achieving better treatment outcomes. This vision of truly personalized cancer care continues to guide everything we do.
Our commitment extends to advancing precision medicine through relentless research and innovation. Using world-leading technology, advanced equipment, and innovative techniques, RGCC’s team of scientists has developed a range of cancer blood tests and innovative technologies designed to support individualized cancer care. Moving away from the traditional “one-size-fits-all” model, this approach uses data-driven analysis to identify the most effective and targeted treatment options tailored for each individual cancer patient.
Guided by this purpose and passion, our vision and mission reflect our commitment to transforming cancer care and shaping the future of truly personalized cancer care.
Our Vision
Our vision is for a world where cancer treatment is truly personalized, harnessing the power of innovative technologies and insights to provide tailored solutions for every individual. We lead the way in advancing personalized medicine, ensuring that patients worldwide receive the most effective and precise cancer treatments.
Our Mission
Since 2004, our mission has been to deliver groundbreaking science which can lead to long-term remissions. We strive to be an indispensable partner for physicians and their patients globally, offering a comprehensive range of cutting-edge tests and innovative solutions. Through our world-class technologies and state-of-the-art laboratories worldwide, we pioneer research and development into personalized cancer treatment.
RGCC is a global organization headquartered in Zug, Switzerland. Our branch offices, modern laboratory facilities, and network of distributors are strategically located worldwide to ensure the highest level of service while supporting regional research initiatives.
RGCC Testing and Innovative Technologies
RGCC combines advanced diagnostics, scientific expertise, and continuous innovation to support a truly personalized approach to cancer care. Our technologies empower clinicians and patients alike, guiding data-driven treatment decisions.
Liquid Biopsy Testing
RGCC applies precision medicine through advanced liquid biopsy testing, analyzing circulating tumor cells (CTCs) and associated biomarkers in the bloodstream. This approach reveals the genetic characteristics of a patient’s cancer and supports the development of individualized treatment approaches.
RGCC testing focuses on:
Cancer Screening
Detecting early indicators of cancer development with Onco-D-Clare.
Cancer Monitoring
Specific RGCC tests support in monitoring diagnosed cancers and as a follow-up surveillance tool for potential metastasis.
Drug & Therapeutic Efficacy
Tests create personalized patient profiles to guide targeted cancer treatments.
Gut Microbiome Profiling
Analyzing the gut microbiome to support personalized cancer care with InVyomma Plus.
Immunity
Assessing immune function and guiding treatment decisions with Immune-Frame.
Innovative Technologies from RGCC
Our team of multidisciplinary scientists combines groundbreaking research with best-in-class technology to develop supportive approaches to patients.
Research & Development
In addition to the clinical services, RGCC’s research and development team focuses on identifying and validating novel cancer drug targets, therapies, and diagnostic approaches. By integrating advanced molecular, cytogenetic, and computational techniques, we continuously work to advance the field of precision oncology.
Our state-of-the-art laboratories each specialize in distinct areas of expertise. Our facilities in Halle (Germany) specialize in cancer drug development and method optimization. Our laboratory facilities in Greece, and our sister company, Welmedis (part of the RGCC Group), are the core in identifying novel cancer targets and developing targeted therapeutics for each cancer profile.
RGCC’s Founder, Dr. Ioannis Papasotiriou
The career of Dr. Ioannis Papasotiriou, MD, PhD, SCym spans multiple disciplines with a drive for groundbreaking research. He pursued a medical degree at Thessaloniki University in Greece before refining his expertise in Human Genetics at the University of Zurich and Hematology Oncology at MLU/UKH/Halle/Saale. He earned two Master’s degrees: one in Molecular Biology in Medicine from Westminster University and another in Molecular Oncology from the University of Nottingham. His doctoral research at MLU University focused on the effects of tyrosine kinase inhibitors (TKIs) on human cancer cell lines, setting the stage for his future innovations.
Dr. Papasotiriou founded RGCC with a steadfast commitment to personalizing cancer care. His dedication and expertise have enabled RGCC to stand at the forefront of individualized cancer treatment, providing hope and healing to patients and their families around the world. Today, RGCC is using world-leading technology, equipment, and innovative techniques to follow his vision. Our team of scientists has developed a range of tests that provide healthcare professionals with comprehensive information about a patient’s genetics, physiology, and immune profiles.
Reasons to Choose RGCC
Every cancer patient and every tumor is unique. Through a variety of tests to personalize cancer care, RGCC aims to empower cancer patients with tailored insights that can change the course of their journey.
For more than 20 years, RGCC has specialized in personalized cancer care. Our extensive experience in liquid biopsy testing and analysis of circulating tumor cells (CTCs), supported by state-of-the-art technologies, provides healthcare professionals with reliable and comprehensive insights into each patient’s genetics, physiology, and immune profile.
Partnering doctors benefit from our extensive knowledge base and a dynamic community worldwide dedicated to advancing precision medicine. RGCC is a trusted partner, upholding internationally recognized accreditations and the highest standards of quality. Discover firsthand experiences from our doctors and patients here to learn about how our personalized technologies have impacted their journeys.
Join our network of healthcare professionals or contact us to find out more about our testing options.